Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Wednesday, November 11, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
World News
Page 57
World News
World News
ΕΠΙΣΤΗΜΟΝΙΚΑ ΝΕΑ
ΖΩΝΤΑΣ ΜΕ ΚΑΡΚΙΝΟ
ΚΑΡΚΙΝΟΣ
ΚΕΝΤΡΑ ΚΑΡΚΙΝΟΥ – ΟΓΚΟΛΟΓΟΙ
Myths and Facts
ΝΕΑ - ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Longer Duration of Treatment with ICIs Associated with a Higher Rate...
Ogkologos
-
March 5, 2025
0
Scientists Find Genetic Changes Linked to Cancer in Children
Ogkologos
-
March 4, 2025
0
Clinical Benefit of Pembrolizumab in Patients with Previously Treated Advanced Clear...
Ogkologos
-
March 4, 2025
0
Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or...
Ogkologos
-
March 3, 2025
0
EMA Recommends Extension of Therapeutic Indications for Lisocabtagene Maraleucel
Ogkologos
-
February 28, 2025
0
FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic, Hormone Receptor-positive, HER2-negative...
Ogkologos
-
February 27, 2025
0
Can AI Help Predict Which Cancer Patients Should Be Treated with...
Ogkologos
-
February 26, 2025
0
Strong Independent Association of TILs with OS for Patients with ERBB2-positive...
Ogkologos
-
February 26, 2025
0
Acalabrutinib-Venetoclax With or Without Obinutuzumab Significantly Prolongs PFS in Fit Patients...
Ogkologos
-
February 25, 2025
0
ESMO Targeted Anticancer Therapies Congress 2025, Paris, France, 3-5 March
Ogkologos
-
February 24, 2025
0
1
...
56
57
58
...
432
Page 57 of 432
MOST POPULAR
Significant Intracranial Efficacy and Survival Benefits of Osimertinib in Patients with...
July 25, 2024
EMA Recommends Granting a Conditional Marketing Authorisation for Selinexor
February 3, 2021
September 11, 2001 – Strength is Not Always Unyielding
September 11, 2021
Optimistic targets aren’t enough – this is what we need to...
July 19, 2023
Load more
HOT NEWS
FDA Approves Updated Drug Labelling Including New Indications and Dosing Regimens...
FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer
PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients...
Can Cancer Symptoms Be Mistaken for Menopause?
Ελληνικά
English (UK)